Becker's Healthcare September 25, 2024
Paige Twenter

Large companies can save millions of dollars by addressing one common misconception about health insurance plans, according to billionaire entrepreneur Mark Cuban.

Mr. Cuban, who entered the pharmaceutical industry as a disruptor in January 2022 with his company, Mark Cuban Cost Plus Drugs, shared his thoughts on pharmacy benefit managers with Becker’s on Sept. 25.

Editor’s note: Responses have been lightly edited for clarity and length.

Question: We’ve talked before about pharmacy benefit managers and why Cost Plus Drugs partners with pass-through PBMs. How do you see the FTC’s recent lawsuit against PBMs influencing the industry?

Mark Cuban: I think it’s a positive step towards transparency. The only real advantage the big PBMs have beyond their size...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Pharma, Pharma / Biotech
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal

Share This Article